Latest filing published 08 Oct 2026 for Biolife Solutions INC. Read the official filing
Aby J. Mathew (senior executive) discloses dealings in Biolife Solutions Inc to SEC (Form 4). Between 15 March 2016 and 6 October 2026, the trades on record add up to 146 filings.
Every open-market trade on record is a sale: 75 sales worth €2.9M. Besides market trades, the filings include 37 share grants and 33 option exercises. So far in 2026, the count stands at no purchases and 2 sales.
On 8 October 2026 came the latest disclosure, a share grant in Biolife Solutions Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 113 declarations